Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management

Immune checkpoint inhibitors (anti-PD-1 and anti-CTLA-4 antibodies) are a standard of care for advanced melanoma. Novel toxicities comprise immune-related adverse events (irAE). With increasing use, irAE require recognition, practical management strategies, and multidisciplinary care. We retrospecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Skin Cancer
Main Authors: Lomax, Anna J., Lim, Jennifer, Cheng, Robert, Sweeting, Arianne, Lowe, Patricia, McGill, Neil, Shackel, Nicholas, Chua, Elizabeth L., McNeil, Catriona
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828308/
https://ncbi.nlm.nih.gov/pubmed/29610684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9602540
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados